Posted by TSA West on February 12, 2002, at 1:01:46
In reply to Reboxetine and weight, posted by Jess on February 11, 2002, at 15:25:33
Good morning Jess,
--I didn't notice "weight gain" mentioned in the side-effects table or in the study at all:
"The majority of newly observed signs and symptoms from Reboxetine treatment began in the first 10 days of treatment, and the mean duration was 10.2 days in the reboxetine group and 2.7 days in the placebo group (p < 0.001). Most were mild to moderate in intensity (94% in the reboxetine group and 98% in the placebo group), and only a small proportion were considered to be severe (6% and 2%, respectively; p = 0.038). A total of 67% of the newly observed signs and symptoms were considered definitely related to treatment in the reboxetine group compared with 38% in the placebo group (p < 0.01). However, the incidence of discontinuations because of newly observed signs and symptoms was equally low in both groups (one patient per group)."
J. of Clin Psychopharmacology, February 2000. "Double-Blind, Placebo-Controlled Study With Reboxetine in Inpatients With Severe Major Depressive Disorder"
poster:TSA West
thread:93773
URL: http://www.dr-bob.org/babble/20020208/msgs/93847.html